A detailed history of Citigroup Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Citigroup Inc holds 147,979 shares of UTHR stock, worth $54.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
147,979
Previous 1,625,605 90.9%
Holding current value
$54.6 Million
Previous $518 Million 89.76%
% of portfolio
0.03%
Previous 0.34%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $460 Million - $537 Million
-1,477,626 Reduced 90.9%
147,979 $53 Million
Q2 2024

Aug 12, 2024

BUY
$228.26 - $319.04 $339 Million - $474 Million
1,485,441 Added 1059.79%
1,625,605 $518 Million
Q1 2024

May 10, 2024

BUY
$210.76 - $249.51 $11.8 Million - $14 Million
55,968 Added 66.47%
140,164 $32.2 Million
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $494,224 - $590,962
2,300 Added 2.81%
84,196 $18.5 Million
Q3 2023

Nov 09, 2023

BUY
$211.82 - $248.24 $2.3 Million - $2.69 Million
10,850 Added 15.27%
81,896 $18.5 Million
Q2 2023

Aug 10, 2023

SELL
$205.19 - $232.99 $2.9 Million - $3.3 Million
-14,151 Reduced 16.61%
71,046 $15.7 Million
Q1 2023

May 11, 2023

BUY
$212.99 - $276.17 $4.51 Million - $5.85 Million
21,170 Added 33.06%
85,197 $19.1 Million
Q4 2022

Feb 09, 2023

SELL
$205.95 - $280.43 $1.81 Million - $2.47 Million
-8,799 Reduced 12.08%
64,027 $17.8 Million
Q3 2022

Nov 10, 2022

BUY
$203.3 - $244.17 $3.5 Million - $4.21 Million
17,223 Added 30.97%
72,826 $15.2 Million
Q2 2022

Aug 10, 2022

BUY
$174.81 - $241.14 $2.93 Million - $4.04 Million
16,751 Added 43.11%
55,603 $13.1 Million
Q1 2022

May 12, 2022

SELL
$166.16 - $213.96 $1.95 Million - $2.52 Million
-11,756 Reduced 23.23%
38,852 $6.97 Million
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $1.16 Million - $1.35 Million
6,268 Added 14.14%
50,608 $10.9 Million
Q3 2021

Nov 10, 2021

BUY
$179.86 - $214.88 $7.97 Million - $9.53 Million
44,340 New
44,340 $8.18 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.